samedan logo
 
 
spacer
home > pmps > Spring 2013
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Spring 2013

   
Text
PDF
Industry Insight 

Industry Insight

Graham Hughes casts his eye over a selection of articles from this issue of PMPS.

 
view
download pdf
bullet
Cool Chain, Cargo & Logistics
Technology Solutions

Brave New World

PMPS talks to Adam Crossno at OnAsset Intelligence about what attracted him to the pharmaceutical industry, the solutions that make the difference between success and failure, and his proudest moments.
 
view
download pdf

Supply Chain Integrity

Risk Mitigation: The Invisible Component of Cold Chain Management

Cold chain management is rapidly developing, and business improvements demonstrate the need for this to continue. Henry Ames at Sensitech highlights the invisible component to success in this area: risk mitigation.

 
view
download pdf
bullet
Labelling 
Smart Packaging

Flexible Pharma

Intelligence in packaging brings many benefits to both pharmaceutical companies and end users. Jeroen van den Brand at Holst Centre and Stuart Cherry at Pyramidion discuss two of the latest solutions.
 
view
download pdf
bullet
Formulations, Ingredients and Excipients
Orally Dispersible Tablets

A Sweeter Deal

Liesbeth Meeus from Cargill Pharma explores the benefits and challenges of using erythritol as an excipient in ODTs, compared to other available options such as mannitol.
 
view
download pdf

Ingredients & Formulation

A Matter of Taste

Taste-masking is an important growth area to overcome bitter-tasting APIs. Jon Fisher and Amie Gehris from The Dow Chemical Company focus on the use of complexation with ion exchange resins.

 
view
download pdf

Spray Drying

Fluid Motion

José Luis Santos and Márcio Temtem at Hovione reveal a new method of applying computational fluid dynamics to pharmaceutical spray drying, enhancing API performance.

 
view
download pdf
bullet
STERILE MANUFACTURING

Packaging Sterilisation

Clean Sweep

Should packaging be given higher priority when a company chooses a method of sterilisation for a new product? Delphine Blondard from Top Clean Packaging Group and Sophie Rouif from Ionisos think so.

 
view
download pdf
bullet
Drug Delivery
Parenteral Delivery Devices

The Perfect Fit

Personalised medicine is the buzzword currently causing much debate within the industry. Andy Fry and Paul Greenhalgh at Team Consulting believe that truly tailored drug delivery devices are both possible and profitable.
 
view
download pdf

Q&A: Drug Delivery

Future Investment

Jean-Marc Pardonge of Aptar Pharma puts forward what he believes should be priorities for innovation today, and predicts how the industry will change over the next decade.

 
view
download pdf

Q&A: Parenterals

Delivering Results

Discussing the latest developments in parenteral packaging, Dividella’s Stefan Knellwolf considers the market of today and forecasts the technology of tomorrow.

 
view
download pdf
bullet
MANUFACTURING
Manufacturing Report

Lifting the Lid

A recent study commissioned by Siemens Industry asks UK manufacturers their opinions on a wide range of topical issues. Alan Johnston reports on the findings.
 
view
download pdf
bullet
RFID & ANTICOUNTERFEITING
Serialisation

Track Back

Steve Wood at Covectra tackles the problem of prescription drug abuse in the US, and considers the use of serialisation as a tool for identifying those involved with drug diversion.
 
view
download pdf
Falsified Medicines Directive

Act Now, Save Later

The new Falsified Medicines Directive is designed to combat counterfeit products across Europe - but can companies adapt without losing production time and costs? Simon Slater at Datamere Software Solutions investigates.
 
view
download pdf
bullet
Validation & Compliance
Generics Regulations

Quality Matters

The generics industry is faced with implementing a number of recent legislative changes. While quality is sure to improve, smaller manufacturers may struggle to keep up, says Michael Gamlen of Gamlen Tableting.
 
view
download pdf
bullet
REVIEW

Book Reviews

Strategies for Success

Graham Hughes reviews two very different handbooks: one examining cleanrooms and the other a practical guide to packaging labelling and artwork.

 
view
bullet
PACKING & PACKAGING

Blister Packaging Technology

The Future’s White

Using White Line technology to package small lots is the latest solution to a shift from high-volume products to low-volume ‘niche’ drugs, argues Körber Medipak’s Andrew Longworth.

 
view
download pdf

Biopolymers

A Natural Choice

Full-scale commercialisation of biopolymers faces many obstacles, yet its major environmental benefits, among other key features, mean that it should not be ruled out, says Smithers Rapra Consultant, Michael Lock.

 
view
download pdf
bullet
MARKETPLACE & BUSINESS

Management & Operations

Smarter Supply Chains

Life sciences companies need to consider the current economic environment and make sensible choices regarding their supply chain operations, emphasises Heather Fraser at IBM.

 
view
download pdf
bullet
The End of the line
The End of the Line

Chain Reaction

Richard Harrop backs the benefits of good communication before even the smallest of decisions are made.
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Drug delivery innovation across Europe improves for third consecutive year ahead of Pharmapack Europe

Paris, 25th June 2021: Ahead of Pharmapack Europe 2021 (Paris Expo, Porte de Versailles, 13-14 October) – the returning European event dedicated to drug packaging and delivery – there has been a huge swathe of innovation across the industry, with more than 53 FDA approvals in 2020 and 26 approvals in 2021.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence

Ludger Ltd

One of the most important classes of biopharmaceuticals is monoclonal antibodies. They are expressed from living cells, and are consequently subject to complex biochemical pathways. Not all of these routes are fully understood, and many are sensitive to the subtlest of environmental changes. Changes such as these can affect the final biopharmaceutical sequence, structure and post-translational modifications, not to mention any changes that may occur during further purification. This often means that the final product from one batch may be different from the last in another batch. Each batch is a complicated mix of similar molecules, and analysis of the degree of batch-to-batch variation is therefore very important to the establishment of the drug's safety for medicinal use and patient administration.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement